Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles W Flexner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 29, 2015
Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatmentAntoinette G Nelson, Xiaoping Zhang, Usha Ganapathi, et al.
The Journal of Infectious Diseases|June 27, 2025
Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic EnhancementSimone Perazzolo, Charles W Flexner, Zachary R Stephen, et al.
AIDS Research and Human Retroviruses|August 9, 2002
Alcohol use and HIV pharmacotherapyThomas F Kresina, Charles W Flexner, Jacqueline Sinclair, et al.
BMC Complementary and Alternative Medicine|August 21, 2008
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavirAdriana S A Andrade, Craig Hendrix, Teresa L Parsons, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteersYing Jun Cao, Charles W Flexner, Shelia Dunaway, et al.
Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 29, 2015
Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatmentAntoinette G Nelson, Xiaoping Zhang, Usha Ganapathi, et al.
The Journal of Infectious Diseases|June 27, 2025
Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic EnhancementSimone Perazzolo, Charles W Flexner, Zachary R Stephen, et al.
AIDS Research and Human Retroviruses|August 9, 2002
Alcohol use and HIV pharmacotherapyThomas F Kresina, Charles W Flexner, Jacqueline Sinclair, et al.
BMC Complementary and Alternative Medicine|August 21, 2008
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavirAdriana S A Andrade, Craig Hendrix, Teresa L Parsons, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteersYing Jun Cao, Charles W Flexner, Shelia Dunaway, et al.
Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Pageof 2